StockData
Ernexa Therapeutics Inc. logo

Ernexa Therapeutics Inc. (ERNA) balance sheet

ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.63+0.01 (+0.62%)

Close on Nov 19, 2026Market cap $2.66MP/E –Yield –

Ernexa Therapeutics Inc. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-686.7%

Financial strength

Current ratio
2.01
Debt to equity
–
Debt to assets
–
Cash to current liabilities
171.5%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.83
Dividend yield
–

See a number that looks wrong?